Delivery Order SPE2DB20D2104-SPE2DB24FR81U
Award Date 12/27/23
Potential Completion Date 12/28/23
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with an ID of SPE2DB20D3104 | SPE2DB22FV4F5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,893.50, is for the delivery of Estrace 0.01% Cream 42.5GM. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical....
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,419.85 firm fixed-price delivery order is for the supply of Estrace 0.01% cream, a topical estrogen medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award, with ID SPE2DB24D2101|SPE2DB25FKJSG, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.24 firm fixed-price delivery order is for the supply of Estrace 0.01% cream, 42.5 gm. This order is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Estrace 0.01% cream. The $1,464.42 firm fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Estrace 0.01% cream in 42.5 gram quantities. The $5,461.26 firm fixed price delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- The federal contract award SPE2DB20D3101|SPE2DB22FH4K7, valued at $1,670.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract involves the delivery of Estrace 0.01% cream, a medication used for various medical conditions. This contract award is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- This federal contract award is for the delivery of Estrace 0.01% cream, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a firm fixed price of $2,486.70. The contract has an ultimate completion date of March 19, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Estrace 0.01% Cream in 42.5 gram units. The $2,002.68 firm fixed-price delivery order is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp., a subsidiary of Amerisourcebergen Corporation, to provide Estrace 0.01% cream. The contract is a firm fixed price delivery order with a ceiling value of $1,736.50 and a period of performance through March 20, 2024. Amerisourcebergen Drug Corp. is the prime contractor for this award, which does not have a set-aside designation. The contract is a part of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,778.64 for the supply of Estrace 0.01% Cream 42.5GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, on January 5, 2023, with a completion date of January 6, 2023. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen is a major pharmaceutical...